Search Results - "Desantes, K"
-
1
Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease
Published in Bone marrow transplantation (Basingstoke) (01-11-2016)Get full text
Journal Article -
2
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
Published in Bone marrow transplantation (Basingstoke) (01-02-2006)“…The major problems with busulfan/cyclophosphamide (Bu/Cy)-containing conditioning regimens are acute toxicities and graft failure. To decrease acute…”
Get full text
Journal Article -
3
An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease
Published in Bone marrow transplantation (Basingstoke) (01-05-2000)“…Autologous recovery is a major problem with busulfan as a marrow ablative agent in conditioning children for allogeneic BMT. Data suggest the average…”
Get full text
Journal Article -
4
Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation
Published in Bone marrow transplantation (Basingstoke) (01-11-1999)“…We report a high incidence (19.5%) of autoimmune hemolytic anemia (AIHA) in 41 patients with SCID who underwent a T cell-depleted haploidentical transplant…”
Get full text
Journal Article -
5
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody
Published in Journal of clinical oncology (01-08-1989)“…The biodistribution, toxicity, and therapeutic potential of anti-CD37 monoclonal antibody (MoAb) MB-1 labeled with iodine 131 (131I) was evaluated in ten…”
Get more information
Journal Article -
6
Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation
Published in Bone marrow transplantation (Basingstoke) (01-03-1997)Get full text
Journal Article -
7
-
8
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
Published in Journal of clinical oncology (01-01-1998)“…The analogue 131I-metaiodobenzylguanidine (MIBG), which is specifically targeted to neuroblastoma cells, may provide more effective and less toxic treatment…”
Get more information
Journal Article -
9
Phase I study of fenretinide (4-HPR) oral powder in patients with recurrent or resistant neuroblastoma: New Approaches to Neuroblastoma Therapy (NANT) Consortium trial
Published in Journal of clinical oncology (20-05-2009)“…Abstract only 10009 Background: Fenretinide (4-HPR), a cytotoxic retinoid, achieved limited and variable plasma levels when tested in a corn oil-based capsule…”
Get full text
Journal Article -
10
Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease
Published in The Journal of clinical investigation (01-07-2003)“…Graft-versus-host disease (GVHD) represents a major cause of morbidity and mortality following conventional allogeneic hematopoietic stem cell transplantation…”
Get full text
Journal Article -
11
Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans
Published in Bone marrow transplantation (Basingstoke) (01-04-2001)“…A distinct form of autosomal recessive T-B- severe combined immunodeficiency disease occurs with a high frequency among Athabascan-speaking Native Americans…”
Get full text
Journal Article -
12
Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation
Published in Bone marrow transplantation (Basingstoke) (01-03-1997)“…Children receiving a bone marrow transplant (BMT) are at risk for neuropsychological late effects because of potentially neurotoxic chemotherapy and total body…”
Get full text
Journal Article -
13
Radiolabeled antibody targeting of the HER-2/neu oncoprotein
Published in Cancer research (Baltimore) (01-04-1992)“…The HER-2/neu oncogene encodes a Mr 185,000 transmembrane phosphoglycoprotein which is overexpressed in 25-35% of breast and ovarian neoplasms and portends a…”
Get full text
Conference Proceeding Journal Article -
14
Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation
Published in Transplantation (15-06-1995)Get more information
Journal Article -
15
Bone marrow transplantation for T super(-)B super(-) severe combined immunodeficiency disease in Athabascan-speaking native Americans
Published in Bone marrow transplantation (Basingstoke) (01-04-2001)“…A distinct form of autosomal recessive T super(-)B super(-) severe combined immunodeficiency disease occurs with a high frequency among Athabascan-speaking…”
Get full text
Journal Article -
16
Bone marrow transplantation in Fanconi anemia using matched sibling donors
Published in Blood (15-09-1994)“…Eighteen patients with Fanconi anemia (FA) with evidence of bone marrow (BM) aplasia underwent allogenic BM transplants (BMT) from matched sibling donors…”
Get full text
Journal Article -
17
Genotypes of NK cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy: A Children’s Oncology Group Report
Published in Cancer research (Chicago, Ill.) (08-10-2010)“…Response to immunocytokine (IC) therapy is dependent on natural killer (NK) cells in murine neuroblastoma (NBL) models. Furthermore, killer immunoglobulin-like…”
Get full text
Journal Article -
18
Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease
Published in Bone marrow transplantation (01-11-2016)Get full text
Report -
19
Maternal mosaicism for a novel interleukin-2 receptor γ-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred
Published in Journal of clinical immunology (1997)“…X-linked severe combined immunodeficiency disease (SCID) results from mutations of IL2RG, the gene encoding the interleukin-2 receptor gamma chain, also known…”
Get full text
Journal Article -
20
Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores
Published in Cancer research (Chicago, Ill.) (15-02-1990)“…The rates of degradation of radioiodinated monoclonal antibodies (MoAbs) by malignant T- and B-lymphoid cells were studied in the presence and absence of a…”
Get full text
Journal Article